Page last updated: 2024-11-07

2-fluoromethylornithine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-fluoromethylornithine: an ornithine decarboxylase antagonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID126431
CHEMBL ID38759
SCHEMBL ID3831417
MeSH IDM0112243

Synonyms (10)

Synonym
alpha-fluoromethylornithine
ornithine, 2-(fluoromethyl)-
2-fluoromethylornithine
CHEMBL38759 ,
73800-85-8
2-(fluoromethyl)ornithine
bdbm50020273
2,5-diamino-2-fluoromethyl-pentanoic acid
SCHEMBL3831417
DTXSID70994780
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Ornithine decarboxylaseRattus norvegicus (Norway rat)Ki38.85002.70002.70002.7000AID150883; AID150884
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID22942The times of half-inactivation constant (T50) was determined for ODC1983Journal of medicinal chemistry, Nov, Volume: 26, Issue:11
alpha-(Fluoromethyl)dehydroornithine and alpha-(fluoromethyl)dehydroputrescine analogues as irreversible inhibitors of ornithine decarboxylase.
AID150884The apparent dissociation constant for irreversible inhibition of rat liver ornithine decarboxylase (ODC)1983Journal of medicinal chemistry, Nov, Volume: 26, Issue:11
alpha-(Fluoromethyl)dehydroornithine and alpha-(fluoromethyl)dehydroputrescine analogues as irreversible inhibitors of ornithine decarboxylase.
AID23588Pharmacokinetic parameter half life was determined1989Journal of medicinal chemistry, Jan, Volume: 32, Issue:1
2,2-Difluoro-5-hexyne-1,4-diamine: a potent enzyme-activated inhibitor of ornithine decarboxylase.
AID150883In vitro inhibition against ornithine decarboxylase1989Journal of medicinal chemistry, Jan, Volume: 32, Issue:1
2,2-Difluoro-5-hexyne-1,4-diamine: a potent enzyme-activated inhibitor of ornithine decarboxylase.
AID23589Pharmacokinetic parameter half life was determined at a concentration of 10 uM1983Journal of medicinal chemistry, Nov, Volume: 26, Issue:11
alpha-(Fluoromethyl)dehydroornithine and alpha-(fluoromethyl)dehydroputrescine analogues as irreversible inhibitors of ornithine decarboxylase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (75.00)18.7374
1990's2 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.13 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]